PropertyValue
?:abstract
  • Antibody cocktails represent a promising approach to prevent SARS-CoV-2 escape. The determinants for selecting antibody combinations and the mechanism that antibody cocktails prevent viral escape remain unclear. We compared the critical residues in the receptor-binding domain (RBD) used by multiple neutralizing antibodies and cocktails and identified a combination of two antibodies CoV2-06 and CoV2-14 for preventing viral escape. The two antibodies simultaneously bind to non-overlapping epitopes and independently compete for receptor binding. SARS-CoV-2 rapidly escapes from individual antibodies by generating resistant mutations in vitro, but it doesn’t escape from the cocktail due to stronger mutational constraints on RBD-ACE2 interaction and RBD protein folding requirements. We also identified a conserved neutralizing epitope shared between SARS-CoV-2 and SARS-CoV for antibody CoV2-12. Treatments with CoV2-06 and CoV2-14 individually and in combination confer protection in mice. These findings provide insights for rational selection and mechanistic understanding of antibody cocktails as candidates for treating COVID-19.
?:creator
?:doi
  • 10.1038/s41467-020-20789-7
?:doi
?:journal
  • Nat_Commun
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/e534b94a3aef598ca0c1fc5b232eaf1adde79364.json; document_parses/pdf_json/c79aa1803da9e2a45dc8a043c024129df908f891.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7817669.xml.json
?:pmcid
?:pmid
?:pmid
  • 33473140.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape
?:type
?:year
  • 2021-01-20

Metadata

Anon_0  
expand all